AuGC BioFund LP
AuGC BioFund LP is a hedge fund based in San Diego, California. According to its most recent Form D, filed Jul 21, 2026, the fund has sold $57,403,508 of interests to 81 investors since its first sale in Jul 2017. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include AuGC Partners LLC; Evan Markegard.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $57,403,508Cumulative sales reported on Form D
- Investors
- 81
- First sale
- Jul 8, 2017
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- AuGC Partners LLC; Evan Markegard
- Latest Form D
- Jul 21, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Jul 21, 2026 | Form D/A (amendment) | $57,403,508 | 81 | SEC.gov ↗ |
| Jul 22, 2025 | Form D/A (amendment) | $29,356,523 | 59 | SEC.gov ↗ |
| Jul 23, 2024 | Form D/A (amendment) | $25,241,523 | 49 | SEC.gov ↗ |
| Jul 28, 2023 | Form D/A (amendment) | $23,041,523 | 43 | SEC.gov ↗ |
| Jul 28, 2022 | Form D/A (amendment) | $22,841,524 | 42 | SEC.gov ↗ |
| Jul 28, 2021 | Form D/A (amendment) | $21,991,524 | 40 | SEC.gov ↗ |
| Jul 31, 2020 | Form D/A (amendment) | $20,636,524 | 35 | SEC.gov ↗ |
| Jul 31, 2019 | Form D/A (amendment) | $14,954,928 | 35 | SEC.gov ↗ |
| Jul 18, 2018 | Form D/A (amendment) | $7,908,336 | 28 | SEC.gov ↗ |
| Jul 5, 2017 | Form D | $0 | 0 | SEC.gov ↗ |
10 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jul 5, 2017. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Questions about AuGC BioFund LP
What is the minimum investment for AuGC BioFund LP?
AuGC BioFund LP's latest Form D, filed Jul 21, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in AuGC BioFund LP?
AuGC BioFund LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has AuGC BioFund LP raised?
AuGC BioFund LP reports $57,403,508 sold from 81 investors on its Form D filed Jul 21, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is AuGC BioFund LP based?
AuGC BioFund LP is based in San Diego, California and is managed by Augc Partners LLC.
When did AuGC BioFund LP launch?
AuGC BioFund LP reports its first sale in Jul 2017.
Size compared with every hedge fund
Raised more than 58% of the 1,049 hedge funds based in California, and more than 49% of all 10,160 that report sales.